Trial NCT00781326

View at ClinicalTrials.gov 
Org. Study IDs: K23MH067710-01
Secondary IDs: DATR AK-TNGP1 K23MH067710-01

Last trial update was posted on 2016-09-29

MeSH Interventions

Nimodipine

MeSH Conditions

Depression Depressive Disorder

Other Conditions


Stopping Reasons

Final cost of study medication was significantly greater than initial estimate,

Limitations And Caveats

Study was terminated for administrative reasons at the end of Phase I (open label antidepressant treatment). No subjects entered Phase II (Nimodipine vs Placebo).

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID